$47.70
1.58% (Daily)
Market Cap
$4.87B
Revenue
$N/A
Rank by MCap
#1595
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. David L. Hallal
Headquarters
Cambridge, MA
Employees
128
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively t...
Loading chart…